Evidence map›Paper›PMID 39341403›Full record

ArticleThe Journal of infection2024

Revealing patterns of SARS-CoV-2 variant emergence and evolution using RBD amplicon sequencing of wastewater.

Xingwen Chen, John Balliew, Cici X Bauer, Jennifer Deegan, Anna Gitter, Blake M Hanson, Anthony W Maresso, Michael J Tisza, Catherine L Troisi, Janelle Rios and 3 more

Abstract read
In one paragraph

Article in The Journal of infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Xingwen ChenSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
John BalliewEl Paso Water Utility, El Paso, TX, USA.
Cici X BauerSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Jennifer DeeganSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Anna GitterSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Blake M HansonSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Anthony W MaressoTAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Michael J TiszaThe Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Catherine L TroisiSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Janelle RiosSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Kristina D MenaSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Eric BoerwinkleSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA.
Fuqing WuSchool of Public Health, University of Texas Health Science Center at Houston, TX, USA; Texas Epidemic Public Health Institute (TEPHI), UTHealth Houston, Houston, TX, USA. Electronic address: fuqing.wu@uth.tmc.edu.

Funding

Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADxUP Phase IIIU01TR004355 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BAUER, CICI, CRUM, MICHELLE · 2023 to 2023
$2.2M
NCATS NIH HHS U01 TR004355
6 · The paper itself

Abstract

objectivesRapid evolution of SARS-CoV-2 has resulted in the emergence of numerous variants, posing significant challenges to public health surveillance. Clinical genome sequencing, while valuable, has limitations in capturing the full epidemiological dynamics of circulating variants in the general population. This study aimed to monitor the SARS-CoV-2 variant community dynamics and evolution using receptor-binding domain (RBD) amplicon sequencing of wastewater samples.

methodsWe sequenced wastewater from El Paso, Texas, over 17 months, compared the sequencing data with clinical genome data, and performed biodiversity analysis to reveal SARS-CoV-2 variant dynamics and evolution.

resultsWe identified 91 variants and observed waves of dominant variants transitioning from BA.2 to BA.2.12.1, BA.4&5, BQ.1, and XBB.1.5. Comparison with clinical genome sequencing data revealed earlier detection of variants and identification of unreported outbreaks. Our results also showed strong consistency with clinical data for dominant variants at the local, state, and national levels. Alpha diversity analyses revealed significant seasonal variations, with the highest diversity observed in winter. By segmenting the outbreak into lag, growth, stationary, and decline phases, we found higher variant diversity during the lag phase, likely due to lower inter-variant competition preceding outbreak growth.

conclusionsOur findings underscore the importance of low transmission periods in facilitating rapid mutation and variant evolution. Our approach, integrating RBD amplicon sequencing with wastewater surveillance, demonstrates effectiveness in tracking viral evolution and understanding variant emergence, thus enhancing public health preparedness.

Indexed as

COVID-19SARS-CoV-2WastewaterEvolution, MolecularGenome, ViralHumansSpike Glycoprotein, CoronavirusTexasSpike Glycoprotein, CoronavirusWastewaterAmplicon sequencingReceptor-binding domainSARS-CoV-2Variant emergenceViral evolutionWastewater surveillance

Identifiers

PMID39341403
PMCPMC13290073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.